Skip to content

TORNAPHAR: what changed

BE 0448.509.588NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€9,903
2024 · €6,343+€3,560
Equity
€928,880
2024 · €918,977+€9,903
Cash
€256,299
2024 · €124,529+€131,770
Balance sheet total
€3.7m
2024 · €3.5m+€213,770

Largest movements

2024 to 2025
Assets
  • Cash +€131,770

    up €131,770 (+106%), from €124,529 to €256,299

    mainly Trade debts (+€188,988) and Depreciation (+€137,048)

  • Tangible fixed assets +€67,235

    up €67,235 (+6.4%), from €1.1m to €1.1m

    of which Land and buildings: +€100,335

Equity and liabilities
  • Trade debts +€188,988

    up €188,988 (+17.2%), from €1.1m to €1.3m

  • Other debts +€94,826

    up €94,826 (+20.2%), from €470,257 to €565,083

  • Debts after one year -€88,289

    down €88,289 (-13.4%), from €657,815 to €569,526

    of which Financial debts: -€88,289

  • Short-term financial debts +€49,336

    up €49,336, from €0 to €49,336

  • Current portion of long-term debt -€40,217

    down €40,217 (-30.6%), from €131,556 to €91,339

Income statement
  • Gross operating margin +€114,151

    up €114,151 (+13.3%), from €858,962 to €973,113

  • Staff costs +€97,920

    up €97,920 (+14.7%), from €665,930 to €763,850

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €6,343
Gross operating margin +€114,151
Staff costs -€97,920
Depreciation -€8,406
Other operating charges -€4,518
Financial income +€1,501
Financial charges +€2,606
Taxes -€3,854
Result 2025 €9,903
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€415,223
Investment -€204,283
Financing -€79,170
Cash 2024 €124,529
Net result for the year +€9,903
Depreciation +€137,048
Stocks and contracts +€720
Receivables within one year -€25,870
Deferred charges and accrued income +€10,385
Provisions -€6,367
Trade debts +€188,988
Tax, wage and social debts +€7,917
Other debts +€94,826
Accrued charges and deferred income -€2,326
Investment in fixed assets (net) -€204,283
Debts after one year -€88,289
Current portion of long-term debt -€40,217
Short-term financial debts +€49,336
Cash 2025 €256,299
brings cash intakes cash out
Every line side by side 63 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,526,057 €3,739,827 +€213,770 +6.1%
Fixed assets 21/28 €2,620,284 €2,687,520 +€67,235 +2.6%
Intangible fixed assets 21 €0 - =
Tangible fixed assets 22/27 €1,054,456 €1,121,692 +€67,235 +6.4%
Land and buildings 22 €969,822 €1,070,157 +€100,335 +10.3%
Plant, machinery and equipment 23 €5,574 €3,749 -€1,824 -32.7%
Furniture and vehicles 24 €65,086 €42,434 -€22,652 -34.8%
Other tangible fixed assets 26 €13,976 €5,352 -€8,624 -61.7%
Financial fixed assets 28 €1,565,828 €1,565,828 = 0.0%
Current assets 29/58 €905,773 €1,052,308 +€146,535 +16.2%
Stocks and contracts in progress 3 €375,753 €375,033 -€720 -0.2%
Stocks 30/36 €375,753 €375,033 -€720 -0.2%
Amounts receivable within one year 40/41 €389,778 €415,648 +€25,870 +6.6%
Trade receivables 40 €369,006 €397,136 +€28,129 +7.6%
Other amounts receivable 41 €20,771 €18,512 -€2,259 -10.9%
Current investments 50/53 €3,327 €3,327 = 0.0%
Cash at bank and in hand 54/58 €124,529 €256,299 +€131,770 +106%
Deferred charges and accrued income 490/1 €12,385 €2,000 -€10,385 -83.9%
Total equity and liabilities 10/49 €3,526,057 €3,739,827 +€213,770 +6.1%
Equity 10/15 €918,977 €928,880 +€9,903 +1.1%
Contributions 10/11 €61,500 €61,500 = 0.0%
Capital 10 €61,500 €61,500 = 0.0%
Issued capital 100 €61,500 €61,500 = 0.0%
Reserves 13 €829,885 €810,785 -€19,100 -2.3%
Non-distributable reserves 130/1 €6,150 €6,150 = 0.0%
Legal reserve 130 €6,150 €6,150 = 0.0%
Tax-exempt reserves 132 €218,949 €199,849 -€19,100 -8.7%
Distributable reserves 133 €604,786 €604,786 = 0.0%
Profit (loss) carried forward 14 €27,592 €56,595 +€29,003 +105%
Provisions and deferred taxes 16 €97,208 €90,841 -€6,367 -6.5%
Deferred taxes 168 €97,208 €90,841 -€6,367 -6.5%
Amounts payable 17/49 €2,509,872 €2,720,107 +€210,235 +8.4%
Amounts payable after more than one year 17 €657,815 €569,526 -€88,289 -13.4%
Financial debts 170/4 €657,815 €569,526 -€88,289 -13.4%
Other amounts payable 178/9 €0 - =
Amounts payable within one year 42/48 €1,846,658 €2,147,507 +€300,850 +16.3%
Current portion of amounts payable after more than one year 42 €131,556 €91,339 -€40,217 -30.6%
Financial debts 43 €0 €49,336 +€49,336
Credit institutions 430/8 €0 €49,336 +€49,336
Trade debts 44 €1,097,306 €1,286,294 +€188,988 +17.2%
Suppliers 440/4 €1,097,306 €1,286,294 +€188,988 +17.2%
Taxes, remuneration and social security 45 €147,539 €155,456 +€7,917 +5.4%
Taxes 450/3 €41,113 €37,257 -€3,856 -9.4%
Remuneration and social security 454/9 €106,426 €118,199 +€11,773 +11.1%
Other amounts payable 47/48 €470,257 €565,083 +€94,826 +20.2%
Accrued charges and deferred income 492/3 €5,400 €3,074 -€2,326 -43.1%
Turnover 70 €0 - =
Goods, raw materials, services and sundry goods 60/61 €0 - =
Remuneration, social security and pensions 62 €665,930 €763,850 +€97,920 +14.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €128,641 €137,048 +€8,406 +6.5%
Other operating charges 640/8 €12,863 €17,382 +€4,518 +35.1%
Gross operating margin 9900 €858,962 €973,113 +€114,151 +13.3%
Operating profit (loss) 9901 €51,527 €54,834 +€3,307 +6.4%
Financial income 75/76B - €1,501 +€1,501
Recurring financial income 75 - €1,501 +€1,501
Financial charges 65/66B €34,849 €32,243 -€2,606 -7.5%
Recurring financial charges 65 €34,849 €32,243 -€2,606 -7.5%
Profit (loss) for the period before taxes 9903 €16,678 €24,092 +€7,414 +44.5%
Transfer from deferred taxes 780 €6,367 €6,367 = 0.0%
Income taxes 67/77 €16,702 €20,556 +€3,854 +23.1%
Profit (loss) for the period 9904 €6,343 €9,903 +€3,560 +56.1%
Transfer from tax-exempt reserves 789 €19,100 €19,100 = 0.0%
Profit (loss) for the period to be appropriated 9905 €25,443 €29,003 +€3,560 +14.0%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€512,650 to €531,935

Midpoint €520,686 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €928,880
Capitalised earnings €96,421 to €134,990
Indication €512,650 to €531,935

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€928,880
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€928,880

Capitalised earnings

net result for the year (9904)
2025
€9,903
2024
€6,343
2023
€24,253
2022
€20,314
2021
€99,439
Average result
€13,499
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€96,421 / €112,492 / €134,990

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.